BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11668159)

  • 1. Costs of different strategies for neonatal hearing screening: a modelling approach.
    Boshuizen HC; van der Lem GJ; Kauffman-de Boer MA; van Zanten GA; Oudesluys-Murphy AM; Verkerk PH
    Arch Dis Child Fetal Neonatal Ed; 2001 Nov; 85(3):F177-81. PubMed ID: 11668159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newborn hearing screening: the great omission.
    Mehl AL; Thomson V
    Pediatrics; 1998 Jan; 101(1):E4. PubMed ID: 9417168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cost-effectiveness analysis of newborn hearing screening strategies.
    Kemper AR; Downs SM
    Arch Pediatr Adolesc Med; 2000 May; 154(5):484-8. PubMed ID: 10807300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of the Automated Auditory Brainstem Response in Neonatal Hearing Screening.
    Levit Y; Himmelfarb M; Dollberg S
    Pediatrics; 2015 Sep; 136(3):e641-7. PubMed ID: 26324873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost and cost-effectiveness of universal screening for hearing loss in newborns.
    Kezirian EJ; White KR; Yueh B; Sullivan SD
    Otolaryngol Head Neck Surg; 2001 Apr; 124(4):359-67. PubMed ID: 11283492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Otoacoustic Emissions in Rural Nicaragua: Cost Analysis and Implications for Newborn Hearing Screening.
    Wong LY; Espinoza F; Alvarez KM; Molter D; Saunders JE
    Otolaryngol Head Neck Surg; 2017 May; 156(5):877-885. PubMed ID: 28457225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Projected cost-effectiveness of statewide universal newborn hearing screening.
    Keren R; Helfand M; Homer C; McPhillips H; Lieu TA
    Pediatrics; 2002 Nov; 110(5):855-64. PubMed ID: 12415021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal otoacoustic emission screening and the identification of deafness.
    Watkin PM
    Arch Dis Child Fetal Neonatal Ed; 1996 Jan; 74(1):F16-25. PubMed ID: 8653430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter evaluation of how many infants with permanent hearing loss pass a two-stage otoacoustic emissions/automated auditory brainstem response newborn hearing screening protocol.
    Johnson JL; White KR; Widen JE; Gravel JS; James M; Kennalley T; Maxon AB; Spivak L; Sullivan-Mahoney M; Vohr BR; Weirather Y; Holstrum J
    Pediatrics; 2005 Sep; 116(3):663-72. PubMed ID: 16140706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newborn hearing screening at a community-based obstetric unit: Screening and diagnostic outcomes.
    de Kock T; Swanepoel D; Hall JW
    Int J Pediatr Otorhinolaryngol; 2016 May; 84():124-31. PubMed ID: 27063767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of otoacoustic emissions, and automated and diagnostic auditory brainstem responses, in high-risk infants.
    Khaimook W; Pantuyosyanyong D; Pitathawatchai P
    J Laryngol Otol; 2019 May; 133(5):363-367. PubMed ID: 31070117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation of long-term impacts of universal newborn hearing screening.
    Chiou ST; Lung HL; Chen LS; Yen AM; Fann JC; Chiu SY; Chen HH
    Int J Audiol; 2017 Jan; 56(1):46-52. PubMed ID: 27598544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of hearing screening programs between one step with transient evoked otoacoustic emissions (TEOAE) and two steps with TEOAE and automated auditory brainstem response.
    Lin HC; Shu MT; Lee KS; Ho GM; Fu TY; Bruna S; Lin G
    Laryngoscope; 2005 Nov; 115(11):1957-62. PubMed ID: 16319605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The economics of screening infants at risk of hearing impairment: an international analysis.
    Burke MJ; Shenton RC; Taylor MJ
    Int J Pediatr Otorhinolaryngol; 2012 Feb; 76(2):212-8. PubMed ID: 22129917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of the costs of implementing the National Newborn Hearing Screening Programme in England.
    Uus K; Bamford J; Taylor R
    J Med Screen; 2006; 13(1):14-9. PubMed ID: 16569300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infant hearing screening: effects of timeline.
    Tsui PW; McPherson B; Wong EC; Ng IH
    Clin Otolaryngol; 2008 Apr; 33(2):108-12. PubMed ID: 18429859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cost-effectiveness analysis of the high risk register and auditory brainstem response.
    Friedland DR; Fahs MC; Catalano PJ
    Int J Pediatr Otorhinolaryngol; 1996 Dec; 38(2):115-30. PubMed ID: 9119600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening strategies for neonatal hearing loss: which test is best?
    Dort JC; Tobolski C; Brown D
    J Otolaryngol; 2000 Aug; 29(4):206-10. PubMed ID: 11003070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An alternative strategy for universal infant hearing screening in tertiary hospitals with a high delivery rate, within a developing country, using transient evoked oto-acoustic emissions and brainstem evoked response audiometry.
    Mathur NN; Dhawan R
    J Laryngol Otol; 2007 Jul; 121(7):639-43. PubMed ID: 17112395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening for hearing loss in newborns at Turku University Central Hospital].
    Sahlberg H; Salonen J; Jääskeläinen S; Lapinleimu H
    Duodecim; 2011; 127(18):1934-41. PubMed ID: 22034731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.